The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index; 36 of the 67 sources its claims cite were checked for support.
TREM2 promotes lung fibrosis via controlling alveolar macrophage survival and pro-fibrotic activity
Open accessAbstract
Lung macrophages play a pivotal role in pulmonary fibrosis, with monocyte-derived alveolar macrophages driving disease progression. However, the mechanisms regulating their pro-fibrotic behavior and survival remain unclear, and effective therapeutic strategies are lacking. Here we show that triggering receptors expressed on myeloid cells 2 are predominantly expressed on monocyte-derived alveolar macrophages in fibrotic mouse lungs and are significantly elevated in lung macrophages from patients with idiopathic pulmonary fibrosis. Deletion or knockdown of this receptor disrupts intracellular survival signaling, promotes macrophage apoptosis, and attenuates their pro-fibrotic phenotype. We further demonstrate that a lipid mediator and a high-avidity ligand of this receptor, encountered by macrophages in the alveolar milieu, enhance macrophage survival and activity. Ablation of TREM2 or blocking this receptor with soluble receptors or specific antibodies effectively alleviates lung fibrosis in male mice. These findings identify this receptor as a critical regulator of macrophage-mediated fibrosis and a promising therapeutic target for intervention. Monocyte-derived alveolar macrophages (Mo-AMs) are involved in lung injury and fibrosis through incompletely understood mechanisms. Here, the authors show that TREM2 is a critical regulator of lung fibrosis progression mediated by Mo-AMs and a potential target for therapeutic intervention.
Overview
CoChat Summary
## TL;DR
TREM2 is highly expressed on monocyte-derived alveolar macrophages in fibrotic mouse lungs and in IPF patient macrophages, where it promotes macrophage survival and pro-fibrotic activity. In mouse models, genetic deletion or pharmacologic blockade of TREM2 reduced bleomycin-induced lung fibrosis, while soluble TREM2 and a blocking antibody disrupted sphingomyelin-driven survival signaling.
## Key findings
- In bleomycin-treated mouse lungs, TREM2 was markedly higher on Mo-AMs than on TR-AMs; in normal mouse lungs it was only moderate on AMs and classical monocytes, with little expression in other cells.
- In human lungs, TREM2 was predominantly restricted to AMs and classical monocytes in normal tissue, and IPF lungs showed more macrophages with greater TREM2 expression; IPF AMs had markedly increased TREM2 versus normal lungs.
- Global TREM2 KO mice had significantly decreased bleomycin-induced fibrosis, including lower lung hydroxyproline levels and diminished pro-fibrotic mediators.
- Mo-AM-specific TREM2 deletion reduced fibrosis in bleomycin-treated mice, with reduced hydroxyproline, less trichrome-stained collagen, and lower micro-CT lung densities; in another model, Mo-AM TREM2(-/-) mice were also protected from TGF-β1-induced fibrosis.
- TREM2 deficiency increased macrophage apoptosis and reduced pro-fibrotic genes/mediators, including lower SPP1, PDGFA, MMP12, and TGF-β1-related signals; TREM2-high macrophages in mouse and IPF lungs expressed more scar-associated and anti-apoptotic markers.
- Sphingomyelin, elevated in BAL from bleomycin-injured mice, protected macrophages from apoptosis in a TREM2-dependent manner; sTREM2 and a TREM2-blocking antibody abolished this protection and attenuated lung fibrosis.
## Methods
- Mouse and human study with bleomycin-induced lung fibrosis in mice, plus a second model using adenovirus expressing constitutively active TGF-β1; comparisons included global TREM2 KO mice and conditional Mo-AM TREM2 deletion mice.
- Human samples came from IPF patients and failed-donor normal lungs; BAL-derived AMs and PBMC-derived macrophages were used for ex vivo assays, and published scRNA-seq datasets were reanalyzed.
- Main analyses included flow cytometry, immunofluorescence, hydroxyproline assay, trichrome staining, micro-CT, apoptosis assays, ELISA, qPCR, Western blotting, lipidomics of BAL fluid, and ATII–Mo-AM alveolosphere co-culture.
## Limitations
- The paper states that the underlying mechanism of TREM2’s intrinsic regulatory activity in macrophages “remains unclear.”
- The authors note that the study’s anti-fibrotic effects were shown in male mice only, because “8–10 weeks male mice were used for all experiments.”
- Evident from the text: much of the human evidence is observational (scRNA-seq reanalysis and microscopy), so it supports association rather than direct causal proof in patients.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
15 Valid · 0 Not valid · 4 Not checked · 83 Own results and interpretations
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“TREM2 expression is frequently associated with scar-associated macrophages (SAMs)40–42.”
§ TREM2 promotes lung fibrosis via controlling alveolar macrophage survival and pro-fibrotic activity > Introduction
What the sources say
- Not checked — no full text of the sourcecites [40] Fabre, T. et al. Identification of a broadly fibrogenic macrophage subset induced by type 3 inflammation. Sci. Immunol. 8, eadd8945 (2023). source
- Supportedcites [41] Henlon, Y. et al. Single-cell analysis identifies distinct macrophage phenotypes associated with prodisease and proresolving functions in the endometriotic niche. Proc. Natl Acad. Sci. USA 121, e2405474121 (2024). source
The Results describe a scar-associated macrophage (SAM-like) cluster characterized by Trem2 expression. The Discussion also lists Trem2 among the markers of the SAM-like population, supporting the stated association. (LLM, conf=0.92)
- Supportedcites [42] Lee, J. et al. Multiplexed digital spatial protein profiling reveals distinct phenotypes of mononuclear phagocytes in livers with advanced fibrosis. Cells 11, 3387 (2022). source
The Results (section 3.5) state that TREM2 and CD9 are selectively upregulated in scar-associated macrophages and can serve as markers for them. The Discussion also names TREM2 as a representative marker of these cells. (LLM, conf=0.93)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“depletion of Mo-AMs via several strategies conferred protection from lung fibrosis in multiple mouse models1,3,10,11,13,20”
§ TREM2 promotes lung fibrosis via controlling alveolar macrophage survival and pro-fibrotic activity > Introduction
What the sources say
- Supportedcites [1] Misharin, A. V. et al. Monocyte-derived alveolar macrophages drive lung fibrosis and persist in the lung over the life span. J. Exp. Med. 214, 2387–2404 (2017). source
The Results (page not available) report reduced Mo-AM numbers and less fibrosis with two genetic targeting strategies in the bleomycin model. They also report attenuated fibrosis in a second, TGF-β–induced mouse model. The Discussion states that deleting Mo-AMs after recruitment markedly attenuated fibrosis in common mouse models. (LLM, conf=0.91)
- Partly supportedcites [3] Watanabe, S., Alexander, M., Misharin, A. V. & Budinger, G. R. S. The role of macrophages in the resolution of inflammation. J. Clin. Invest. 129, 2619–2628 (2019). sourceExperimental — accuracy not yet measured
The review (Role of macrophages in tissue repair, p. 5) does state that 'the deletion of monocyte-derived macrophages ameliorates fibrosis during bleomycin-induced lung injury (13, 76)', and Macrophages in homeostasis (p. 2) notes that selective deletion strategies have been used to demonstrate a contribution of monocyte-derived alveolar macrophages to tissue injury and fibrosis — so the core of the claim is supported. However, our copy ties this protective effect to a single model (bleomycin-induced lung injury); it does not report protection 'in multiple mouse models' via 'several strategies' (the only other lung fibrosis model it discusses, asbestos, concerns resident interstitial macrophages not contributing to the profibrotic pool, p. 6). The same p. 5 passage also qualifies the claim in the opposite direction: depletion of both tissue-resident and monocyte-derived macrophages late in fibrosis delays resolution (76), and p. 6 cautions that genetic depletion kills macrophages by necrosis and may itself induce tissue damage. (LLM, conf=0.72)
- Could not verifycites [10] McCubbrey, A. L. et al. Selective and inducible targeting of CD11b+ mononuclear phagocytes in the murine lung with hCD68-rtTA transgenic systems. Am. J. Physiol. Lung Cell Mol. Physiol. 311, L87–L100 (2016). sourceExperimental — accuracy not yet measured
Figure 10 and the accompanying results report activation of a reporter in recruited macrophages after bleomycin injury, not depletion or protection from fibrosis. The Discussion proposes manipulating recruited-macrophage survival as a future experiment. Searches for depletion and fibrosis did not find the claimed protective effect in multiple mouse models. (LLM, conf=0.75)
- Partly supportedcites [11] McCubbrey, A. L. et al. Deletion of c-FLIP from CD11b(hi) macrophages prevents development of bleomycin-induced lung fibrosis. Am. J. Respir. Cell Mol. Biol. 58, 66–78 (2018). sourceExperimental — accuracy not yet measured
The Results report that reducing CD11bhi macrophages protected mice from bleomycin-induced lung fibrosis. However, the Discussion says the intervention targeted both alveolar and tissue CD11bhi macrophages, so this study does not isolate depletion of monocyte-derived alveolar macrophages. It also tests one depletion strategy in one mouse model, rather than multiple strategies or models. (LLM, conf=0.88)
- Supportedcites [13] Joshi, N. et al. A spatially restricted fibrotic niche in pulmonary fibrosis is sustained by M-CSF/M-CSFR signalling in monocyte-derived alveolar macrophages. Eur. Respir. J. 55, 1900646 (2020). source
The Results section on genetic deletion reports that reducing monocyte-derived alveolar macrophages lessened asbestos-induced fibrosis in mice. The Results section on M-CSF/M-CSFR signalling also reports that two pharmacological treatments reduced these cells and fibrosis severity. This paper supplies the asbestos-model evidence for the multiply cited sentence; it need not establish every mouse model on its own. (LLM, conf=0.88)
- Not checked — no full text of the sourcecites [20] Gibbons, M. A. et al. Ly6Chi monocytes direct alternatively activated profibrotic macrophage regulation of lung fibrosis. Am. J. Respir. Crit. Care Med. 184, 569–581 (2011). source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“these sphingolipids and phospholipids are well-characterized high-avidity ligands of TREM232”
§ TREM2 promotes lung fibrosis via controlling alveolar macrophage survival and pro-fibrotic activity > Results > Sphingomyelin protects macrophages from apoptosis
What the sources say
- Partly supportedcites [32] Wang, Y. et al. TREM2 lipid sensing sustains the microglial response in an Alzheimer’s disease model. Cell 160, 1061–1071 (2015). sourceExperimental — accuracy not yet measured
The Results section, “TREM2 is a sensor for anionic and zwitterionic lipids,” reports TREM2 reporter activation by several phospholipids and non-phosphate lipids, including sphingomyelin and sulfatides. It does not establish that these lipids are high-avidity ligands; responses varied, and cardiolipin did not significantly activate the reporter. (LLM, conf=0.86)
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The pathogenic role of Mo-AMs in lung fibrosis has been largely attributed to their activity in producing a number of pro-fibrotic mediators, such as TGF-β, PDGF-α, osteopontin (OPN), and MMPs1,3,11,13,15,18,28.”
§ TREM2 promotes lung fibrosis via controlling alveolar macrophage survival and pro-fibrotic activity > Introduction
What the sources say
- Partly supportedcites [1] Misharin, A. V. et al. Monocyte-derived alveolar macrophages drive lung fibrosis and persist in the lung over the life span. J. Exp. Med. 214, 2387–2404 (2017). sourceExperimental — accuracy not yet measured
The Results (page unavailable) identify Pdgfa and Mmp12/13/14 among genes implicated in fibrotic signaling in Mo-AMs, and the Discussion reports higher profibrotic gene expression in Mo-AMs than in resident alveolar macrophages. The paper does not establish that production of the listed mediators largely explains their pathogenic role; the retrieved passages do not identify osteopontin as a Mo-AM product or show Mo-AM production of TGF-β. (LLM, conf=0.86)
- Partly supportedcites [3] Watanabe, S., Alexander, M., Misharin, A. V. & Budinger, G. R. S. The role of macrophages in the resolution of inflammation. J. Clin. Invest. 129, 2619–2628 (2019). sourceExperimental — accuracy not yet measured
The only passage in our copy listing these molecules (Role of macrophages in tissue repair, p. 5, 'Mechanisms of macrophage-mediated tissue repair') presents TGFβ, PDGFA, MMP-8/-10/-28 and osteopontin as factors macrophages secrete to actively PROMOTE TISSUE REPAIR (refs 65-67), not as pro-fibrotic mediators of Mo-AM pathogenicity in lung fibrosis. Our copy does support that monocyte-derived alveolar macrophages contribute to lung injury and fibrosis (Macrophages in homeostasis, p. 2; Role of macrophages in tissue repair, p. 5: 'deletion of monocyte-derived macrophages ameliorates fibrosis during bleomycin-induced lung injury'), but it never ties that pathogenic role to production of the listed mediators — indeed it reports Mo-AMs as necessary for collagen breakdown and that their late depletion delays resolution. The mediator overlap is real; the attribution of them as Mo-AM-derived pro-fibrotic effectors in fibrosis is not this paper's statement. (LLM, conf=0.75)
- Partly supportedcites [11] McCubbrey, A. L. et al. Deletion of c-FLIP from CD11b(hi) macrophages prevents development of bleomycin-induced lung fibrosis. Am. J. Respir. Cell Mol. Biol. 58, 66–78 (2018). sourceExperimental — accuracy not yet measured
The Results and Discussion report that CD11bhi macrophages produce profibrotic chemokines, growth factors, and matrix-remodeling proteins in bleomycin-injured mice. But the Discussion says the study could not distinguish recruited alveolar from tissue CD11bhi macrophages, and our copy does not identify TGF-β, PDGF-α, osteopontin, or MMPs as the mediators produced by Mo-AMs. (LLM, conf=0.88)
- Partly supportedcites [13] Joshi, N. et al. A spatially restricted fibrotic niche in pulmonary fibrosis is sustained by M-CSF/M-CSFR signalling in monocyte-derived alveolar macrophages. Eur. Respir. J. 55, 1900646 (2020). sourceExperimental — accuracy not yet measured
The Results section on single-cell RNA sequencing identifies Spp1 (osteopontin), Mmp12, and Mmp14 among pro-fibrotic genes enriched in the Mo-AM-associated AM3 cluster. The Results section on fibroblast activation also reports Pdgfa expression in Mo-AMs. But the paper lists Tgfb1 with the generic genes of AM1 and AM2, not AM3, and its gene-expression findings do not establish production of all four mediators by Mo-AMs. Page numbers are unavailable in our copy. (LLM, conf=0.87)
- Partly supportedcites [15] McQuattie-Pimentel, A. C. et al. The lung microenvironment shapes a dysfunctional response of alveolar macrophages in aging. J. Clin. Invest. 131, e140299 (2021). sourceExperimental — accuracy not yet measured
Our copy supports only the general half of the attribution: Results p. 8 states that deletion of MoAMs attenuates bleomycin-induced lung fibrosis (refs. 8, 26, 38) and that newly recruited MoAMs show increased expression of inflammatory and fibrotic genes, and that MoAMs recruited after a second bleomycin challenge express higher levels of fibrosis-associated genes/GO processes with worse compliance and collagen (Figure 9, B–F). The specific mechanistic part of the claim — that this pathogenicity is attributed to production of TGF-β, PDGF-α, osteopontin and particular MMPs — is absent: searches for osteopontin/Spp1, Tgfb, Pdgf and matrix metalloproteinase returned no passage naming these as MoAM-derived pro-fibrotic mediators (the matrix genes our copy does list, e.g. Col4a2, Hspg2, Fn1, Tnc on Results p. 6, concern the AT2/macrophage ligand-receptor interactome in aging, not MoAM secretion in fibrosis). Note also that this paper's own focus is aging/microenvironment rather than a mediator-based account of MoAM pathogenicity. (LLM, conf=0.68)
- Partly supportedcites [18] Aran, D. et al. Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage. Nat. Immunol. 20, 163–172 (2019). sourceExperimental — accuracy not yet measured
The Results (‘CX3CR1-expressing macrophages drive lung fibrosis’) and Discussion identify profibrotic macrophages as a source of PDGF-AA and link it to fibroblast proliferation. The passages support that mediator, but do not establish macrophage production of TGF-β, osteopontin, or MMPs as the basis of their pathogenic role. (LLM, conf=0.88)
- Partly supportedcites [28] Young, L. R. et al. Epithelial-macrophage interactions determine pulmonary fibrosis susceptibility in Hermansky-Pudlak syndrome. JCI Insight 1, e88947 (2016). sourceExperimental — accuracy not yet measured
Young et al. (2016) support only the TGF-β component: the Discussion (p. 8) states that the MCP-1/CCR2 axis regulated excess TGFβ production by HPS macrophages and that deleting TGFβ in myeloid cells protected against bleomycin-induced fibrosis, and the Results (pp. 5, 7) show macrophage TGFβ1 production is CCR2-dependent. The introduction (p. 2) frames recruited/alveolar macrophages as implicated in lung fibrosis but hedged ('macrophages may alternately promote fibrosis or resolution at different times after injury (10-18)'). Our copy nowhere attributes to monocyte-derived alveolar macrophages the production of PDGF-α, osteopontin, or a panel of MMPs — the only MMP mention is the title of a cited work (ref. 29, Okuma et al. 2004, Acknowledgments p. 14), and the paper does not use the term Mo-AM or enumerate pro-fibrotic mediators. So the multi-mediator list and the 'largely attributed to producing a number of pro-fibrotic mediators' framing are not supported by this source. (LLM, conf=0.72)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“This antibody is particularly useful because it can specifically demonstrate the effect of receptor TREM2 blockade without the confounding activity of antibody-dependent cellular cytotoxicity or antibody-dependent phagocytosis in vivo.”
§ TREM2 promotes lung fibrosis via controlling alveolar macrophage survival and pro-fibrotic activity > Results > TREM2 blocking antibody abolishes the protective effect of SM and attenuates lung fibrosis in bleomycin-treated mice
What the sources say
- Supportedcites [38] Molgora, M. et al. TREM2 modulation remodels the tumor myeloid landscape enhancing anti-PD-1 immunotherapy. Cell 182, 886–900.e817 (2020). source
In Results, “Anti-TREM2 Treatment Is Protective in the Sarcoma Model,” the authors state that mAb 178’s Fc domain was mutated to prevent Fc-receptor and complement recognition and consequent ADCC or ADCP. The same section reports that the antibody blocks TREM2 ligand binding and did not deplete TREM2-positive macrophages in vivo, supporting its use to examine receptor blockade without those confounding activities. (LLM, conf=0.93)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
65 more claims
Create a free account to see all 102 claims and to verify the 8 references still open.
- It may state two separate claims as one. 16
- Probably not a substantial claim. 20
- The quote only partly states this claim. 1
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ TREM2 promotes lung fibrosis via controlling alveolar macrophage survival and pro-fibrotic activity > Results > Mo-AM TREM2 inhibits alveolar type II (ATII) cells regeneration and differentiation into alveolar type I (ATI) cells
“flow-sorted ATIIs from Sftpc-Cre/tdTomato mice were mixed with isolated TREM2 (+/+) or TREM2 (-/-) Mo-AMs (1:5 ratio) in Matrigel”
§ TREM2 promotes lung fibrosis via controlling alveolar macrophage survival and pro-fibrotic activity > Results > Mo-AM TREM2 inhibits alveolar type II (ATII) cells regeneration and differentiation into alveolar type I (ATI) cells
“we found significantly more and larger organoids when ATIIs were co-cultured with TREM2 (-/-) Mo-AMs than with the TREM2 (fl/fl) counterparts”
Citations
Cites
A Unique Microglia Type Associated with Restricting Development of Alzheimer’s Disease
Keren-Shaul, H., Spinrad, A., Weiner, A., Matcovitch-Natan, O., Dvir-Szternfeld, R., Ulland, T. K., David, E., Baruch, K., Lara-Astaiso, D., Toth, B., et al. (2017) · Cell · doi:10.1016/j.cell.2017.05.018 · Cited by 5,493 · cited 1×
“Recent studies on TREM2 have been heavily concentrated in the realm of Alzheimer ’ s disease since several TREM2 variants were found to be closely associated with the onset of this pathology 29,30,33,36,37 .”
Self-citationAran, D., Looney, A. P., Liu, L., Wu, E., Fong, V., Hsu, A., Chak, S., Naikawadi, R. P., Wolters, P. J., Abate, A. R., et al. (2019) · Nature Immunology · doi:10.1038/s41590-018-0276-y · Cited by 4,984
Resolving the fibrotic niche of human liver cirrhosis at single-cell level
Ramachandran, P., Dobie, R., Wilson-Kanamori, J. R., Dora, E. F., Henderson, B. E. P., Luu, N. T., Portman, J. R., Matchett, K. P., Brice, M., Marwick, J. A., et al. (2019) · Nature · doi:10.1038/s41586-019-1631-3 · Cited by 1,784
TREM2 Lipid Sensing Sustains the Microglial Response in an Alzheimer’s Disease Model
Wang, Y., Cella, M., Mallinson, K., Ulrich, J. D., Young, K. L., Robinette, M. L., Gilfillan, S., Krishnan, G. M., Sudhakar, S., Zinselmeyer, B. H., et al. (2015) · Cell · doi:10.1016/j.cell.2015.01.049 · Cited by 1,736
Self-citationLipid-associated macrophages control metabolic homeostasis in a Trem2-dependent manner
Jaitin, D. A., Adlung, L., Thaiss, C. A., Weiner, A., Li, B., Descamps, H., Lundgren, P., Bleriot, C., Liu, Z., Deczkowska, A., et al. (2019) · Cell · doi:10.1016/j.cell.2019.05.054 · Cited by 1,377 · cited 1×
“Recent studies on TREM2 have been heavily concentrated in the realm of Alzheimer ’ s disease since several TREM2 variants were found to be closely associated with the onset of this pathology 29,30,33,36,37 .”
Self-citationTREM2 Maintains Microglial Metabolic Fitness in Alzheimer’s Disease
Ulland, T. K., Song, W. M., Huang, S. C.-C., Ulrich, J. D., Sergushichev, A., Beatty, W. L., Loboda, A. A., Zhou, Y., Cairns, N. J., Kambal, A., et al. (2017) · Cell · doi:10.1016/j.cell.2017.07.023 · Cited by 1,263
Self-citationReyfman, P. A., Walter, J. M., Joshi, N., Anekalla, K. R., McQuattie-Pimentel, A. C., Chiu, S., Fernandez, R., Akbarpour, M., Chen, C.-I., Ren, Z., et al. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201712-2410oc · Cited by 1,203
Monocyte-derived alveolar macrophages drive lung fibrosis and persist in the lung over the life span
Misharin, A. V., Morales-Nebreda, L., Reyfman, P. A., Cuda, C. M., Walter, J. M., McQuattie-Pimentel, A. C., Chen, C.-I., Anekalla, K. R., Joshi, N., Williams, K. J. N., et al. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20162152 · Cited by 1,133
The role of macrophages in the resolution of inflammation
Watanabe, S., Alexander, M., Misharin, A. V., & Budinger, G. R. S. (2019) · Journal of Clinical Investigation · doi:10.1172/jci124615 · Cited by 925 · cited 6×
“The pathogenic role of Mo-AMs in lung fi brosis has been largely attributed to their activity in producing a number of pro-fi brotic mediators, such as TGF-β , PDGF-α , osteopontin (OPN), and MMPs 1,3,11,13,15,18,28 .”
InfluentialFlow Cytometric Analysis of Macrophages and Dendritic Cell Subsets in the Mouse Lung
Misharin, A. V., Morales-Nebreda, L., Mutlu, G. M., Budinger, G. R. S., & Perlman, H. (2013) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2013-0086ma · Cited by 838 · cited 1×
“Mo-AMs and TR-AMs can be readily separated by fl ow cytometry based on a set of typical cell surface markers 8 – 12 .”
Cited by
Decoding organ fibrosis: mechanistic insights and emerging therapeutic strategies
Chen, X., Zhang, J., Guo, L., Wu, C., Zhou, J., Xu, M., Mo, L., Li, Y., & He, J. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02532-0 · Cited by 58
Zhang, M., Lin, X., He, J., Zuo, Y., Fan, Q., Agida, I. O., Tan, H., Zhu, C., Cheng, J., & Wang, T. (2025) · Redox Biology · doi:10.1016/j.redox.2025.103752 · Cited by 19
Nada, H., Yuan, S., Gaamouch, F. E., Cho, S. W., Kuncewicz, K., Calvo‐Barreiro, L., & Gabr, M. T. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.118358 · Cited by 14
Macrophage heterogeneity in liver fibrosis
Wang, W., Li, S., Liu, Y., Ding, X., Yang, Y., Chen, S., Cao, J., Tacke, F., Dong, W., & Lan, T. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1639455 · Cited by 8
“Notably, TREM2 also promotes lung fi brosis via protecting against macrophage apoptosis (107), while itaconate secreted by TREM2 + macrophages prevents apoptosis in cardiomyocytes and stimulates the growth of fi broblasts, which in turn enhances the process of cardiac tissue repair (108).”
Wang, X., Moy, J. K., Wang, Y., Smith, G. R., Ruf-Zamojski, F. M., Przytycki, P. F., Sealfon, S. C., & Zhou, L. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26168098 · Cited by 9
Metadata
- Authors
- Cui, H., Banerjee, S., Xie, N., Hussain, M., Jaiswal, A., Liu, H., Kulkarni, T., Antony, V. B., Liu, R.-M., Colonna, M., & Liu, G.
- Affiliations
- University of Alabama at Birmingham (US)
- Washington University in St. Louis (US)
- Corresponding author
- Liu, Gang
- ORCID
- Venue
- Nature Communications
- Published
- 2025-02-19
- Volume
- 16
- Issue
- 1
- Pages
- 1761-1761
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC11840137
- OpenAlex
- W4407745349
- Cited by
- 74
- References
- 63
- Citations by year
- 2026: 63 · 2025: 11
- FWCI
- 48.20
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc-nd
- creativecommons.org/licenses/by-nc-nd/4.0 (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0 (vor)
- Locations
- Nature Communications (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Digital Commons@Becker (Washington University School of Medicine) (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- U.S. Department of Health & Human Services | National Institutes of Health (R35HL135830, R01AI170913)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Life Sciences › Immunology and Microbiology › Immunology › Inflammation biomarkers and pathways
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Keywords
- TREM2, pulmonary fibrosis, idiopathic pulmonary fibrosis, alveolar macrophages, macrophage survival, macrophage apoptosis, therapeutic target
- MeSH terms
- Animals, Cell Survival, Female, Humans, Lung, Male, Membrane Glycoproteins, Mice, Inbred C57BL, Pulmonary Fibrosis, Receptors, Immunologic, Signal Transduction, Macrophages, Alveolar, Apoptosis, Mice, Knockout, Mice, Idiopathic Pulmonary Fibrosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: TREM2 promotes lung fibrosis via controlling alveolar macrophage survival and pro-fibrotic activity. https://app.cochat.ai/papers/10.1038/s41467-025-57024-0
- The paper
- Cui, H., Banerjee, S., Xie, N., Hussain, M., Jaiswal, A., Liu, H., Kulkarni, T., Antony, V. B., Liu, R.-M., Colonna, M., & Liu, G. (2025). TREM2 promotes lung fibrosis via controlling alveolar macrophage survival and pro-fibrotic activity. Nature Communications. https://doi.org/10.1038/s41467-025-57024-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.